These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6684259)

  • 41. Acetazolamide-responsive periodic ataxia induced by amiodarone.
    Onofrj M; Thomas A
    Mov Disord; 1999 Mar; 14(2):379-81. PubMed ID: 10091644
    [No Abstract]   [Full Text] [Related]  

  • 42. [Episodic ataxia without myokymia].
    Yabe I; Sasaki H
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):322-5. PubMed ID: 12483892
    [No Abstract]   [Full Text] [Related]  

  • 43. Episodic ataxias as channelopathies.
    Griggs RC; Nutt JG
    Ann Neurol; 1995 Mar; 37(3):285-7. PubMed ID: 7535034
    [No Abstract]   [Full Text] [Related]  

  • 44. [A clinical trial of acetazolamide for SCA6].
    Yabe I; Sasaki H; Yamashita I; Takei A; Fukazawa T; Hamada T; Tashiro K
    Rinsho Shinkeigaku; 1999 Aug; 39(8):793-9. PubMed ID: 10586621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Paroxysmal cerebellar ataxia--an evaluation using the findings from magnetic resonance imaging, positron emission tomography, and acetazolamide treatment].
    Araki S; Kawamura M; Shiota J; Isono O; Hirayama K
    Rinsho Shinkeigaku; 1990 Apr; 30(4):416-9. PubMed ID: 2387111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial periodic ataxia.
    Hankey GJ; Gubbay SS
    Med J Aust; 1989 Mar; 150(5):277-8. PubMed ID: 2716626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Episodic ataxia type 2: unusual aspects in clinical and genetic presentation. Special emphasis in childhood.
    Bertholon P; Chabrier S; Riant F; Tournier-Lasserve E; Peyron R
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1289-92. PubMed ID: 19864665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.
    García Segarra N; Gautschi I; Mittaz-Crettol L; Kallay Zetchi C; Al-Qusairi L; Van Bemmelen MX; Maeder P; Bonafé L; Schild L; Roulet-Perez E
    J Neurol Sci; 2014 Jul; 342(1-2):69-78. PubMed ID: 24836863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Familial paroxysmal ataxia: a new case].
    Escribano JB; Moltó JM; Martínez-García FA; Morales A; Jiménez-Martínez JM; Fernández-Barreiro A
    Rev Neurol; 1996 May; 24(129):567-9. PubMed ID: 8681176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of acetazolamide on myotonia.
    Griggs RC; Moxley RT; Riggs JE; Engel WK
    Ann Neurol; 1978 Jun; 3(6):531-7. PubMed ID: 677818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions.
    Imbrici P; Altamura C; Gualandi F; Mangiatordi GF; Neri M; De Maria G; Ferlini A; Padovani A; D'Adamo MC; Nicolotti O; Pessia M; Conte D; Filosto M; Desaphy JF
    Mol Cell Neurosci; 2017 Sep; 83():6-12. PubMed ID: 28666963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel frameshift mutation in the CACNA1A gene causing a mixed phenotype of episodic ataxia and familiar hemiplegic migraine.
    Kinder S; Ossig C; Wienecke M; Beyer A; von der Hagen M; Storch A; Smitka M
    Eur J Paediatr Neurol; 2015 Jan; 19(1):72-4. PubMed ID: 25468264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache.
    Magis D; Boon E; Coppola G; Daron A; Schoenen J
    Cephalalgia; 2012 Nov; 32(15):1147-9. PubMed ID: 22942164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis.
    Ptáĉek LJ; Tawil R; Griggs RC; Meola G; McManis P; Barohn RJ; Mendell JR; Harris C; Spitzer R; Santiago F
    Neurology; 1994 Aug; 44(8):1500-3. PubMed ID: 8058156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acetazolamide-responsive myotonia congenita.
    Trudell RG; Kaiser KK; Griggs RC
    Neurology; 1987 Mar; 37(3):488-91. PubMed ID: 3822145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop.
    Cricchi F; Di Lorenzo C; Grieco GS; Rengo C; Cardinale A; Racaniello M; Santorelli FM; Nappi G; Pierelli F; Casali C
    J Neurol Sci; 2007 Mar; 254(1-2):69-71. PubMed ID: 17292920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.
    Tacik P; Guthrie KJ; Strongosky AJ; Broderick DF; Riegert-Johnson DL; Tang S; El-Khechen D; Parker AS; Ross OA; Wszolek ZK
    Mayo Clin Proc; 2015 Mar; 90(3):366-71. PubMed ID: 25659636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis.
    Bain PG; O'Brien MD; Keevil SF; Porter DA
    Ann Neurol; 1992 Feb; 31(2):147-54. PubMed ID: 1575453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetazolamide in the treatment of abnormal oculovestibular response.
    Hester RB; Farris BK
    Am J Ophthalmol; 1991 Feb; 111(2):215-20. PubMed ID: 1992743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hereditary episodic ataxia].
    Riant F; Vahedi K; Tournier-Lasserve E
    Rev Neurol (Paris); 2011 May; 167(5):401-7. PubMed ID: 21492892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.